All terms in GO

Label Id Description
negative regulation of cardiac endothelial to mesenchymal transition GO_0062001 [Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac endothelial to mesenchymal transition.]
positive regulation of cardiac endothelial to mesenchymal transition GO_0062000 [Any process that activates or increases the frequency, rate or extent of cardiac endothelial to mesenchymal trnasition.]
jasmonoyl-isoleucine-12-hydroxylase activity GO_0052694 [Catalysis of the reaction: jasmonoyl-isoleucine + NADPH + H+ + O2 = 12-hydroxy-jasmonoyl-isoleucine + NADP+ + H2O.]
epoxyqueuosine reductase activity GO_0052693 [Catalysis of the reaction: epoxyqueuosine in tRNA + reductant = queuosine in tRNA + oxidised reductant.]
obsolete flavonoid glucuronidation GO_0052696 [OBSOLETE. The modification of a flavonoid by the conjugation of glucuronic acid. The resultant flavonoid glucuronosides are often much more water-soluble than the precursor.]
obsolete cellular glucuronidation GO_0052695 [OBSOLETE. The modification of an organic chemical by the conjugation of glucuronic acid. The substances resulting from glucuronidation are known as glucuronosides (or glucuronides) and are often much more water-soluble than the non-glucuronic acid-containing precursor.]
trichloro-p-hydroquinone reductive dehalogenase activity GO_0052690 [Catalysis of the reaction: 2,3,6-trichlorohydroquinone + 2 glutathione = 2,6-dichlorohydroquinone + glutathione disulfide + HCl.]
raffinose alpha-galactosidase activity GO_0052692 [Catalysis of the reaction: raffinose + H2O = alpha-D-galactose + sucrose.]
UDP-arabinopyranose mutase activity GO_0052691 [Catalysis of the reaction: UDP-beta-L-arabinofuranose = UDP-beta-L-arabinopyranose.]
obsolete xenobiotic glucuronidation GO_0052697 [OBSOLETE. The modification of a xenobiotic substance by the conjugation of glucuronic acid. The resultant glucuronosides are often much more water-soluble than the xenobiotic precursor, enabling efficient excretion.]
mitochondrial respiratory chain complex IV pre-assembly complex GO_0062011 [A protein complex that contributes to and regulates mitochondrial respiratory chain complex IV (COX) formation. It acts by regulating mitochondrial COX1 translation and by promoting the assembly of COX components.]
primitive palate development GO_0062010 [The biological process whose specific outcome is the progression of the primitive palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure.]
P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential GO_0086039 [A calcium-transporting P-type ATPase activity involved in regulation of the plasma membrane potential.]
calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential GO_0086038 [Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: Ca2+(in) + Na+(out) = Ca2+(out) + Na+(in), which contributes to regulating the membrane potential of a cardiac muscle cell.]
GARP complex binding GO_0062069 [Binding to a GARP complex.]
NuA4 histone acetyltransferase complex binding GO_0062060 [Binding to a NuA4 histone acetyltransferase complex.]
box C/D methylation guide snoRNP complex binding GO_0062064 [Binding to a box C/D methylation guide snoRNP complex.]
BBSome binding GO_0062063 [Binding to a BBSome complex.]
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation GO_0086030 [An adrenergic receptor signaling pathway that contributes to a reduction in cardiac muscle contraction. Beta-adrenergic receptor-induced cardiac relaxation is achieved by a GPCR-activated adenylate cyclase generating cAMP; cAMP then activates the cAMP-dependent protein kinase A (PKA), which phosphorylates the sarcoplasmic reticulum (SR) membrane protein PLB. In its non-phosphorylated state, PLB acts as an inhibitor of the ATPase Ca(2+) pump of the cardiac SR (SERCA2a); inhibition of the pump is relieved upon phosphorylation. The pump removes Ca(2+) from the cytoplasm, thereby preventing cytosolic Ca(2+)-dependent activation of contractile proteins, leading to enhanced muscle relaxation.]
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process GO_0086023 [The series of molecular signals beginning with a G protein-coupled adrenergic cell surface receptor combining with epinephrine or norepinephrine, to activate adenylate cyclase, which contributes to a circulatory system process carried out by the heart.]